R. Addeo et al   Protracted Low Dose of Oral Vinorelbine and Temozolomide with Whole-Brain Radiotherapy in the Treatment for Breast Cancer Patients with Brain Metastases   Cancer Chemotherapy Pharmacology,  Published online 14 August 2012

S. Sutherland et al Treatment of HER2-Positive Metastatic Breast Cancer with Lapatinib and Capecitabine in the Lapatinib Expanded Access Programe, including Efficacy in Brain Metastases-the UK Experience British Journal of Cancer  2010 (102):995-102

M. Abboud et al Complete Response of Brain Metastases from Breast Cancer Overexpressing Her-2/neu to Radiation and Concurrent Lapatinib and Capecitabine The Breast Journal 2010 Vol.16:6

C. Moreira et al  Lapatinib and Breast Cancer: Current Indications and Outlook for the Future  Expert Rev Anticancer Ther. Aug 2010 10(8):1171-82

C. Platta  Current Treatment Strategies for Brain Metastasis and Complications from Therapeutic Techniques: A Review of Current Literature  Am J Clin Oncol Aug 2010 33(4):398-47

B. Besse et al   Bevacizumab (Avastin) Safety in Patients With Central Nervous System Metastases  Clinical Cancer Research Jan 1 2010 16(1):269-78

W. Jacot et al  Carmustine and Methotrexate in Combination after Whole Brain Radiation Therapy in Breast Cancer Patients Presenting with Brain Metastases: A Retrospective Study  BMC (BioMed Central) Cancer June 4 2010 10:257 (free full text)

S. Gluck et al  Lapatinib Plus Capecitabine Resolved Human Epidermal Growth Factor Receptor 2-Positive Brain Metastases Am J Ther. Nov Dec 2009 16(6):585-90

P. Barrett-Lee et al  Contemporary Issues and the Potential Uses of Capecitabine (Xeloda) in Metastatic Breast Cancer  Cancer Treatment Review Nov 2009 35(7):582-9

K. Ito et al  A Case of Brain Metastases from Breast Cancer that Responded to Anastrozole Monotherapy (Arimidex)  Breast Journal Jul-Aug 2009 15(4):435-7

W. Gilbert  The Role of Chemotherapy in the Treatment of Patients with Brain Metastases from Solid Tumors  International Journal of Clinical Oncology Aug 2009 14(4):299-306

S. Labidi  Bevacizumab and Paclitaxel for Breast Cancer Patients with Central Nervous System Metastases: A Case Series  Clincial Breast Cancer May 2009 ((2): 118-21

K. Yonemori et al  Immunohistochemical Profiles of Brain Metastases from Breast Cancer Journal of Neurooncol Nov 2008 90(2):223-8

N. Lin, L. Carey, E. Winer et al Phase 11 Trial of Lapatinib for Brain Metastases in Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer  Journal of Clinical Oncology, April 20, 2008; 26 (12): 1993-1999 

S. Goyal, T. Puri , K. Rath et al Excellent Response fo Letrozole in Brain Metastases from Breast Cancer   Acta Neurochirurgica, 2008; (150): 613-615

B. Moy and P. Goss. Lapatinib-Associated Toxicity and Practical Management Recommendations   The Oncologist, 2007; (12): 756-765. (Free full text)

M Ekenel, A. Hormigo, L Abrey et al Capecitabine Therapy of Central Nervous System Metastases from Breast Cancer   Journal of Neurooncology, 2007; (85) 223-227

G. Shah and L. Abrey Chemotherapy for Brain Metastases: Breast, Gynecologic and Non-Melaoma Skin Malignancies   Cancer Treatment and Research, 2007; 136:185-197

J. Drappatz and P. Wen Chemotherapy and Targeted Molecular Therapies for Brain Metastases Expert Review Neurotherapeutics , 2006; 6 (10): 1465-1479.

A. Fabi, A. Vidiri, G. Ferretti et al Dramatic Regression of Multiple Brain Metastases from Breast Cancer with Capecitabine (Xeloda): Another Arrow in the Bow Cancer Investigations (Letter to the Editor), 2006; 24: 466-468.

A.Lassman, L. Abrey, G. Shah et al Systemic High-Dose Intravenous Methotrexate for Central Nervous System Metastases Journal of Neuro-Oncology, 2006; 78: 255-260.

R. Madhup,  S. Kirti, M. Bhatt et al Letrozole (Femara) for Brain and Scalp Metastases from Breast Cancer- a Case Report  The Breast, 2006; 15: 440-442.

M. Fenner and K. Possinger Chemotherapy for Breast Cancer Brain Metastases Onkologie, 2002; 25: 474-479.

N. U. Lin, V. Dieras, D. Paul, D. Lossignol, C. Christodoulou, D. Laessig, H. Roché, D. Zembryki, C. R. Oliva, E. P. Winer, EGF105084 Study Group. EGF105084, a phase II study of lapatinib for brain metastases in patients (pts) with HER2+ breast cancer following trastuzumab (H) based systemic therapy and cranial radiotherapy (RT).  Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007: 1012 (Slide presentation online).

N. U. Lin, L. A. Carey, M. C. Liu, J. Younger, S. E. Come, E. Bullitt, A. D. Van Den Abbeele, X. Li, F. H. Hochberg, E. P. Winer. Phase II trial of lapatinib for brain metastases in patients with HER2+ breast cancer.  Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings Part I. Vol 24, No. 18S (June 20 Supplement), 2006: 503. (Slide presentation online).

Charles E. Geyer, M.D., John Forster, M.Sc., Deborah Lindquist, et al. Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer. The New England Journal of Medicine, December 28, 2006, number 26, 355:2733-2743 (full text with free registration).